上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1396Please respect copyright.PENANAFxrtbjYHdo
1396Please respect copyright.PENANAQDLSxqBDef
上集:https://www.penana.com/article/4711251396Please respect copyright.PENANAt0KN3f4xUY
1396Please respect copyright.PENANAbHlaMw7EKN1396Please respect copyright.PENANASkGeB4DGRh
1396Please respect copyright.PENANA8pQAvWUR9S
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1396Please respect copyright.PENANAtdq3TrlqV7
1396Please respect copyright.PENANAaVvofevdl6
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1396Please respect copyright.PENANAWC7X2zrjeM
1396Please respect copyright.PENANAxxKQtfBLyF
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1396Please respect copyright.PENANAjOvQah8yKH
1396Please respect copyright.PENANA9cqAjcf9dT1396Please respect copyright.PENANAiITOMjojjU
1396Please respect copyright.PENANARC0wW5vkxo
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1396Please respect copyright.PENANAmXqqNsE2wW
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1396Please respect copyright.PENANAXxSUkB8y4t
1396Please respect copyright.PENANAsqt60Hm8eP
忘記甚麼是Neoantigen的話,可重溫上一集。1396Please respect copyright.PENANAifGCZkvrPL
1396Please respect copyright.PENANAZspls74UPs
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1396Please respect copyright.PENANALGaFUk55Xx
1396Please respect copyright.PENANAEL1CP4bzuo
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1396Please respect copyright.PENANAE1CmGFFela
1396Please respect copyright.PENANA2LIekxgari1396Please respect copyright.PENANAa6SpphBoAC
1396Please respect copyright.PENANAbcu1zw9ikq
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1396Please respect copyright.PENANA1iMoAKjPEI
1396Please respect copyright.PENANAGtxdukoCJz
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1396Please respect copyright.PENANAl1Q7JZ8hd6
1396Please respect copyright.PENANAMHvdVtn3F3
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1396Please respect copyright.PENANAd39paAxH3j1396Please respect copyright.PENANAlZZ8JmjfRj
1396Please respect copyright.PENANAGcmrXKIazQ
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1396Please respect copyright.PENANA7rEFpH3k1z
1396Please respect copyright.PENANAQEhGcZ3Vbn
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1396Please respect copyright.PENANAiYXXhxKUCS1396Please respect copyright.PENANA6wgaxzW9od
1396Please respect copyright.PENANAcL8TGJvPd0
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1396Please respect copyright.PENANADQzQ5Y0NK0
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1396Please respect copyright.PENANA7qCKQc7Thj
1396Please respect copyright.PENANAdvEKatawDU
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1396Please respect copyright.PENANAc9EuEqJ5c9
1396Please respect copyright.PENANA1Sc3pS3fcX
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1396Please respect copyright.PENANAVzn5qE1b6c
1396Please respect copyright.PENANAgJ3aCWZLKp
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1396Please respect copyright.PENANAiaTNwbmgHo
1396Please respect copyright.PENANAdc0RX2wFG0
1396Please respect copyright.PENANAOpqHcR2o51
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1396Please respect copyright.PENANA7y3fBnPU14
1396Please respect copyright.PENANAWHDUchPNfK
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1396Please respect copyright.PENANAULdNVvtCOe
1396Please respect copyright.PENANABoOcdGmaGq
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1396Please respect copyright.PENANADHtAcpLuNj
1396Please respect copyright.PENANAXHVQXtWHeY
Link:1396Please respect copyright.PENANAOS460iIk6x
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1396Please respect copyright.PENANAtc5ikezVif
1396Please respect copyright.PENANAYRw4nOevuk
1396Please respect copyright.PENANAJoJOIgPFfq
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1396Please respect copyright.PENANAnUkWuhGqYS